Company / Return on Assets (ROA)
Aclaris Therapeutics, Inc. Return on Assets (ROA) History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-40.5%
FY2025
5-year range
-46.0% / -34.1%
FY2021-FY2025
Trend
-0.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) has fluctuated over the past 9 years, ranging from -187.5% in FY2020 to -8.4% in FY2017.
Based on SEC 10-K filings.
-40.5% in FY2025 with a 5-year CAGR of +147.1%.
Improved from -46.0% to -40.5% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -6.3pp
- 5-Year Change
- +147.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 0.7% year-over-year.
- Peak return on assets (roa) was recorded in FY2017.
- Lowest return on assets (roa) in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -5.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -40.5% | -0.7% |
| FY2024 | -40.2% | +12.8% |
| FY2023 | -46.0% | -34.8% |
| FY2022 | -34.1% | +5.6% |
| FY2021 | -36.2% | +80.7% |
| FY2020 | -187.5% | -169.0% |
| FY2019 | -69.7% | -44.7% |
| FY2018 | -48.2% | -470.7% |
| FY2017 | -8.4% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026